76 related articles for article (PubMed ID: 27426703)
1. Efficacy of carnosine on activation of caspase 3 and human renal carcinoma cell inhibition.
Pandurangan M; Mistry B; Enkhataivan G; Kim DH
Int J Biol Macromol; 2016 Nov; 92():377-382. PubMed ID: 27426703
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of natural dipeptide carnosine against human cervical carcinoma cells.
Pandurangan M; Enkhtaivan G; Kim DH
J Mol Recognit; 2016 Sep; 29(9):426-35. PubMed ID: 27000946
[TBL] [Abstract][Full Text] [Related]
3. Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas.
Pan BF; Nelson JA
Cancer Chemother Pharmacol; 2007 Apr; 59(5):697-702. PubMed ID: 17009030
[TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma.
Li L; Gao Y; Zhang L; Zeng J; He D; Sun Y
Cancer Lett; 2008 Dec; 272(1):61-9. PubMed ID: 18723275
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in human renal cell carcinoma cells by vitamin E succinate in caspase-independent manner.
Wu XX; Kakehi Y; Jin XH; Inui M; Sugimoto M
Urology; 2009 Jan; 73(1):193-9. PubMed ID: 18692875
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of caspase activation and apoptosis in renal tubular epithelial cells and renal cell carcinomas.
Davidson K; Percy C; Rennick AJ; Pat BK; Li J; Nicol D; Johnson DW; Gobe GC
Nephron Exp Nephrol; 2005; 99(4):e112-20. PubMed ID: 15711100
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
8. Cafestol, a coffee-specific diterpene, induces apoptosis in renal carcinoma Caki cells through down-regulation of anti-apoptotic proteins and Akt phosphorylation.
Choi MJ; Park EJ; Oh JH; Min KJ; Yang ES; Kim YH; Lee TJ; Kim SH; Choi YH; Park JW; Kwon TK
Chem Biol Interact; 2011 Apr; 190(2-3):102-8. PubMed ID: 21334318
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (FLCN).
Lu X; Boora U; Seabra L; Rabai EM; Fenton J; Reiman A; Nagy Z; Maher ER
Oncogene; 2014 Feb; 33(8):956-65. PubMed ID: 23416984
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of renal cell carcinoma to aminoflavone: role of CYP1A1.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Hose C; Linehan WM; Worrell R; Rubinstein L; Sausville EA; Vistica DT
J Urol; 2004 Apr; 171(4):1688-97. PubMed ID: 15017268
[TBL] [Abstract][Full Text] [Related]
11. Effect of a zinc L-carnosine compound on acid-induced injury in canine gastric mucosa ex vivo.
Hill TL; Blikslager AT
Am J Vet Res; 2012 May; 73(5):659-63. PubMed ID: 22533397
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the ubiquitin-proteasome pathway activates stress kinases and induces apoptosis in renal cancer cells.
Ishizawa J; Yoshida S; Oya M; Mizuno R; Shinojima T; Marumo K; Murai M
Int J Oncol; 2004 Sep; 25(3):697-702. PubMed ID: 15289872
[TBL] [Abstract][Full Text] [Related]
13. Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma.
Kolenko V; Uzzo RG; Bukowski R; Bander NH; Novick AC; Hsi ED; Finke JH
Cancer Res; 1999 Jun; 59(12):2838-42. PubMed ID: 10383143
[TBL] [Abstract][Full Text] [Related]
14. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
[TBL] [Abstract][Full Text] [Related]
15. Immunoelectron microscopic demonstration of the membrane proteases aminopeptidase N/CD13 and dipeptidyl peptidase IV/CD26 in normal and neoplastic renal parenchymal tissues and cells.
Stange T; Kettmann U; Holzhausen HJ
Eur J Histochem; 2000; 44(2):157-64. PubMed ID: 10968363
[TBL] [Abstract][Full Text] [Related]
16. Salidroside reduces renal cell carcinoma proliferation by inhibiting JAK2/STAT3 signaling.
Lv C; Huang Y; Liu ZX; Yu D; Bai ZM
Cancer Biomark; 2016 Jun; 17(1):41-7. PubMed ID: 27314291
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
[TBL] [Abstract][Full Text] [Related]
18. Invasive ability of human renal cell carcinoma cell line Caki-2 is accelerated by gamma-aminobutyric acid, via sustained activation of ERK1/2 inducible matrix metalloproteinases.
Inamoto T; Azuma H; Sakamoto T; Kiyama S; Ubai T; Kotake Y; Watanabe M; Katsuoka Y
Cancer Invest; 2007 Oct; 25(7):574-83. PubMed ID: 18027151
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.
Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK
Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727
[TBL] [Abstract][Full Text] [Related]
20. Identification of TGF-β-activated kinase 1 as a possible novel target for renal cell carcinoma intervention.
Meng F; Li Y; Tian X; Fu L; Yin Y; Sui C; Ma P; Jiang Y
Biochem Biophys Res Commun; 2014 Oct; 453(1):106-11. PubMed ID: 25261726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
